Literature DB >> 6605069

The pelvis after surgery for rectal carcinoma: serial CT observations with emphasis on nonneoplastic features.

F M Kelvin, M Korobkin, D K Heaston, J P Grant, O Akwari.   

Abstract

Ten asymptomatic patients who had undergone resection of rectal carcinoma were evaluated prospectively by at least three serial computed tomographic (CT) examinations of the pelvis within 24 months of surgery. Of the seven patients who had undergone abdominoperineal resection, five were found to have a presacral mass due to normal postoperative changes within the first 4 months. The mass showed a variable diminution between 4 and 9 months after operation and developed a more distinct outline, partial separation from the sacrum, or a change in configuration to a thin transverse sliver. These changes indicate the possibility of CT differentiation of a normal postoperative mass from local recurrence. In the other five patients, no postoperative mass was observed. In one patient CT demonstrated a solitary 1.5 cm lymph node metastasis. This patient was asymptomatic and had a normal carcinoembryonic antigen level. From these observations, a baseline CT study of the pelvis within 2-4 months of resection of rectal carcinoma, followed by serial CT examinations at about 6-month intervals is recommended for the detection of early asymptomatic pelvic recurrence and to facilitate differentiation from persistent postoperative changes.

Entities:  

Mesh:

Year:  1983        PMID: 6605069     DOI: 10.2214/ajr.141.5.959

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  9 in total

1.  CT of radiation-induced injury of the gastrointestinal tract: spectrum of findings with barium studies correlation.

Authors:  M Boudiaf; P Soyer; J P Pelage; M Kardache; J Nemeth; A C Dufresne; R Rymer
Journal:  Eur Radiol       Date:  2000       Impact factor: 5.315

2.  [Improvements in detection of rectal cancer recurrence by multiplanar reconstruction].

Authors:  C A Stückle; K F Haegele; M Jendreck; R Kickuth; O Schneider; G Hohlbach; D Liermann
Journal:  Radiologe       Date:  2005-10       Impact factor: 0.635

3.  FDG-PET/MRI in patients with pelvic recurrence of rectal cancer: first clinical experiences.

Authors:  Verena Plodeck; Nuh N Rahbari; Juergen Weitz; Christoph G Radosa; Michael Laniado; Ralf-Thorsten Hoffmann; Klaus Zöphel; Bettina Beuthien-Baumann; Joerg Kotzerke; Joerg van den Hoff; Ivan Platzek
Journal:  Eur Radiol       Date:  2018-07-06       Impact factor: 5.315

Review 4.  Monitoring tumour response.

Authors:  J E Husband
Journal:  Eur Radiol       Date:  1996       Impact factor: 5.315

5.  FDG-PET/CT Is Superior to Enhanced CT in Detecting Recurrent Subcentimeter Lesions in the Abdominopelvic Cavity in Colorectal Cancer.

Authors:  Hai Jeon Yoon; Jong Jin Lee; Yu Kyeong Kim; Sang Eun Kim
Journal:  Nucl Med Mol Imaging       Date:  2011-04-20

Review 6.  CT scanning in carcinoma of the rectum: a review.

Authors:  M P Williams; J E Husband
Journal:  J R Soc Med       Date:  1987-11       Impact factor: 18.000

7.  Diagnostic performance of 18F-fluorodeoxyglucose-PET/MRI versus MRI alone in the diagnosis of pelvic recurrence of rectal cancer.

Authors:  Verena Plodeck; Ivan Platzek; Johannes Streitzig; Heiner Nebelung; Sophia Blum; Jens-Peter Kühn; Ralf-Thorsten Hoffmann; Michael Laniado; Enrico Michler; Sebastian Hoberück; Klaus Zöphel; Jörg Kotzerke; Johannes Fritzmann; Jürgen Weitz; Christoph G Radosa
Journal:  Abdom Radiol (NY)       Date:  2021-08-17

8.  Detection of locally recurrent colorectal cancer with radiolabeled monoclonal antibody H-15.

Authors:  J Sakamoto; T Kato; T Watanabe; H Murayama; K Wada; T Sato; H Takagi; K Kondo; F Sasaki; C Kido
Journal:  Jpn J Cancer Res       Date:  1992-12

Review 9.  Comparison of the diagnostic efficiency for local recurrence of rectal cancer using CT, MRI, PET and PET-CT: A systematic review protocol.

Authors:  Hongsheng Shao; Xueni Ma; Ya Gao; Jiancheng Wang; Jiarui Wu; Bo Wang; Jipin Li; Jinhui Tian
Journal:  Medicine (Baltimore)       Date:  2018-11       Impact factor: 1.817

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.